Mark C. Poznansky,Stephen J. McCormack,Michael Callahan,Jeffrey A. Gelfand,Huabiao Chen,Patrick Reeves
申请号:
US16612109
公开号:
US20200093789A1
申请日:
2018.05.10
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention relates to methods and compositions for treating cancer and enhancing the immune response against cancer cells using the combination of an inhibitor of CXCL12 signaling and an immune checkpoint inhibitor. The invention further relates to compositions and kits of parts comprising an inhibitor of CXCL 12 signaling and an immune checkpoint inhibitor for use in the methods of the invention.